Rasino Drugs Private Limited

This company manufactures pharmaceutical formulations and ingredients for various medical purposes.

2015 | Thane, Maharashtra (India) | Active
Last Updated:

Rasino Drugs Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.20 M
  • Company Age 9 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 5.46 Cr
  • Satisfied Charges ₹ 3.00 Cr
  • Revenue Growth 59.94%
  • Profit Growth -416.11%
  • Ebitda -67.32%
  • Net Worth -8.94%
  • Total Assets 8.10%

About Rasino Drugs

Rasino Drugs Private Limited (RDPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 November 2015 (Nine years and four months 19 days old ). Its registered office is in Thane, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.

The company currently has active open charges totaling ₹5.46 Cr. The company has closed loans amounting to ₹3.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

Paresh Doshi and Swarada Doshi serve as directors at the Company.

Company Details

  • Location

    Thane, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24233MH2015PTC270493

  • Company No.

    270493

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    26 Nov 2015

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Rasino Drugs Private Limited offer?

Rasino Drugs Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Organic Compounds, Chemical Compound, Chemical Raw Material, Pharma Ingredients & Raw Materials, Anti Infective API, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Miconazole Nitrate API, API Intermediate.

Company report

Rasino Drugs Private Limited

Explore comprehensive data for Rasino Drugs Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Rasino Drugs?

Board Members (2)

NameDesignationAppointment DateStatus
Paresh Doshi Country flag representing In Director 26-Nov-2015Current
Swarada Doshi Country flag representing In Director 26-Nov-2015Current

Financial Performance of Rasino Drugs.

Rasino Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.94% increase. The company also saw a substantial fall in profitability, with a 416.11% decrease in profit. The company's net worth dipped by a decrease of 8.94%.

Rasino Drugs revenue growth over time
Rasino Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
59.94%
Revenue from Operations
58.24%
Total Assets
8.10%
Profit or Loss
-416.11%
Net Worth
-8.94%
EBITDA
-67.32%

What is the Ownership and Shareholding Structure of Rasino Drugs?

In 2023, Rasino Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹54.58 M

Satisfied Charges

₹29.98 M

Charges Breakdown by Lending Institutions

  • Others : 5.46 Cr

Latest Charge Details

DateLenderAmountStatus
04 Jan 2024Others₹5.46 CrOpen
22 Apr 2022Axis Bank Limited₹2.58 MSatisfied
20 Aug 2018Axis Bank Limited₹2.74 CrSatisfied

How Many Employees Work at Rasino Drugs?

Rasino Drugs has a workforce of 19 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Rasino Drugs Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rasino Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rasino Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Rasino Drugs

Recent activity within the organization

  • Annual General Meeting

    Rasino Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Charges

    A charge with Others of Rs. 54.58 M registered on 04 Jan 2024 with Charge ID 100863896 was modified on 02 Apr 2024.

  • Balance Sheet

    Rasino Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Charges

    A charge with Others amounted to Rs. 54.58 M with Charge ID 100863896 was registered on 04 Jan 2024.

  • Charges

    A charge registered on 22 Apr 2022 via Charge ID 100564638 with Axis Bank Limited was fully satisfied on 12 Sep 2023.

  • Charges

    A charge registered on 20 Aug 2018 via Charge ID 100202369 with Axis Bank Limited was fully satisfied on 12 Sep 2023.

Frequently asked questions

  • What is the Incorporation or founding date of Rasino Drugs Private Limited?

    Rasino Drugs Private Limited was incorporated on 26 Nov 2015.

  • What is authorized share capital and paid-up capital of Rasino Drugs Private Limited?

    The authorized share capital of Rasino Drugs Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.20 M.

  • Who are the current board members & directors of Rasino Drugs Private Limited?

    Currently 2 directors are associated with Rasino Drugs Private Limited.

    • Paresh Pratap Doshi
    • Swarada Paresh Doshi

  • What is the registered address of Rasino Drugs Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Rasino Drugs Private Limited is Plot No.N-18 Additional Midc, Anand Nagar India, Ambernath, Maharashtra, 421506.

  • What is the corporate identification number (CIN) and company number of Rasino Drugs Private Limited?

    The corporate identification number (CIN) of Rasino Drugs Private Limited is U24233MH2015PTC270493 and the company number is 270493 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Rasino Drugs Private Limited?

    The Official website of Rasino Drugs Private Limited is https://www.rasinodrugs.com

  • What has been the recent revenue trend for Rasino Drugs Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Rasino Drugs Private Limited has risen by 59.94%.

  • How many employees does Rasino Drugs Private Limited currently have?

    As Per 2023 financial reports, 19 employees are currently employed by Rasino Drugs Private Limited.

  • What change has been observed in the net worth of Rasino Drugs Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Rasino Drugs Private Limited has experienced an downturn of -8.94%.

  • What are the total open charges for Rasino Drugs Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Rasino Drugs Private Limited amount to ₹ 5.46 Cr.

  • When was the last Balance Sheet of Rasino Drugs Private Limited filed with the ROC?

    The most recent Balance Sheet for Rasino Drugs Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on API Manufacturers